PKD with GFR 23 and creatinine 2.3

PKD with GFR 23 and creatinine 2.3 Polycystic Kidney Disease (PKD) is a progressive renal disorder with numerous kidney cysts. As renal function deteriorates, GFR will decrease and creatinine will increase. What is the treatment for PKD with GFR 23 and creatinine 2.3?

PKD with GFR 23 and creatinine 2.3

Measures GFR how much blood is filtered by glomeruli every minute. The normal range of GFR is between 90-125ml / min. It is a very sensitive index in measuring kidney function and will be reduced once the kidneys are deteriorated.

Creatinine is the byproduct of muscle metabolism and is eliminated by kidneys. The normal serum creatinine level is 0.6-1.3. For powerful compensatory capacity of kidneys, creatinine level does not increase until more than 50% of renal function is lost. Thus creatinine 2.3 is associated with severe renal insufficiency.

PKD is prominent with numerous cysts in the kidneys. With age, cysts are increasing in both size and number. Enlarged cysts will increasingly replace nephrons, leading to declining renal function.

Treatment for PKD with GFR 23 and creatinine 2.3

The treatment goals of PKD with GFR 23 and creatinine 2.3 should include shrinking large cysts, purifying blood, and controlling large renal cysts.

Micro-Chinese medicine Osmotherapy an help patients achieve the above treatment goals. It is a natural therapy in which different types of Chinese herbs are applied in the same disease-based patients. First, Chinese medicines can kill to cyst wall cladding cells to stop producing cystic fluid. Second, effective medicine ingredients can improve the cyst wall permeability and correct the pressure difference inside and outside cyst wall. The liquid cystic will be absorbed into blood circulation and then be leaked out of body in urine. If so, enlarged cysts will shrink. Thirdly, Chinese medicines can repair impaired nephrons to improve kidney function noticeably.

If the above treatment goals can be achieved, renal function will be markedly improved. GFR 23 will be improved and creatinine 2.3 will be reduced fundamentally.